New appointment at Xiota
This article was originally published in Scrip
Xiota (UK), a life science consultancy launched in May 2008, has made a new appointment to its panel of consultants. Based in Sri Lanka, Simon Lazenbatt will join the international team with responsibility for the operation of Xiota in the Middle East and Asia. He has more than 25 years' experience having previously worked at several companies, including SmithKline Beecham, Grünenthal and Goldshield Group.
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.